Status
Conditions
Treatments
About
The Impact of Metformin and Dipeptidyl Peptidase- 4 Inhibitors on Cognitive Function and cardiovascular protection in Type 2 Diabetic Patients
Full description
This study aims to investigate the effect of daily oral DPP4 inhibitors and oral metformin on neurodegeneration in type 2 diabetic patients.
This study aims to compare between the cardiovascular protective properties of DPP-4 inhibitors and Metformin in type 2 diabetic patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
• Diabetic patients who have been currently receiving anti-diabetic agents other than metformin and/or insulin
60 participants in 2 patient groups
Loading...
Central trial contact
Dalia Zaafar; Toka H Elemary
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal